The synthesis and separation of diastereoisomerically pure 5'-O-DMT-nucleoside 3'-O-(2-thio-1,3,2-oxathiaphospholane) allows their use as synthons in DBUcatalyzed reaction with the 5'-hydroxyl function of solid-support-bound nucleoside moiety. Since this reaction is stereospecific (>99%), this novel method allows preparation of oligo(nucleoside phosphorothioates) (1) with predetermined chirality at each P-chiral internucleotide phosphorothioate centre.
INTRODUCTION
The original observation of increased stability of dialkyl(aryl)phosphorothioates towards nucleases (1) became the basis for the application of oligonucleotide phosphorothioates (7) in modulation of gene expression, as successfully demonstrated by Matsukura et al. (2) and Agrawal et al. (3) .
It has also been demonstrated recently that double-stranded phosphorothioate oligonucleotides are able to accumulate in cells more effectively than native double-stranded oligonucleotides, and to modulate gene expression in a specific manner, most probably by competition for binding of specific transcription factors, and in this way may provide antiviral, immunosuppressive, or other therapeutic effects (4) . Phosphorothioate oligonucleotides prepared by currently available technology (5) consist of a mixture of 2" diastereoisomers, where n is the number of P-chiral phosphorothioate centers. Unfortunately, there are no available analytical tools for direct measurement of the reproducibility of preparing a diastereoisomeric population of phosphorothioate oligonucleotides for n>3.
Since in the aforementioned biological studies phosphorothioate oligonucleotides are used in concentrations several-to-many orders of magnitude higher than their targets such as mRNA (when applied in an antisense manner) or regulatory proteins, one may assume that a target 'selects' the most appropriate population of diastereoisomers with regard to the chirality of phosphorothioate linkages. On the other hand, documented stereoselectivity of some nucleases towards dinucleoside (3', 5') phosphorothioates (1) suggests that stereocontrolled synthesis of phosphorothioate oligonucleotides with predetermined chirality at each P-stereogenic center might allow one to obtain certain diastereoisomers which are most resistant towards nucleolytic enzymes, thus increasing their life-time, and in this way decreasing the required amount of xenobiotic material for a given therapeutic effect.
In addition to this practical aspect, stereo-defined phosphorothioate oligonucleotides could become uniquely informative tools for studies of mechanisms of their interaction with target macromolecules, and, in theory, their stereodifferentiated cell-uptake and, distribution, and metabolism can also be considered.
Although there are several reports on the stereocontrolled preparation of dinucleoside phosphorothioates (6, 7) , in only one case has there been successful preparation of a longer molecule, namely (RpRpRp)-and (SpSpSp)-tetrafthymidine phosphorothioate] (8). However, this later synthesis was performed in solution, and further application of the methodology to automated solid phase synthesis of longer oligonucleotides seems to be unlikely (8) . In this report we wish to present a novel approach to the chemical synthesis of phosphorothioate oligonucleotides (7) . More importantly, this approach allows stereocontrolled synthesis of 1 and utilizes base-catalyzed nucleophilic substitution at a pentavalent phosphorothioyl center.
It has been previously reported from this laboratory that alkylene [ 18 O]l,2-oxides react with unsymmetrical dialkyl phosphorothioates with full retention of configuration at phosphorus (9) O]phosphate (10) . This stereochemical result was rationalized in terms of involvement of intermediates containing a 2-oxo-l,3,2-oxathiaphospholane ring system. The observed stereospecificity for the overall process prompted us to formulate a hypothesis in which nucleoside 3'-O[2-thio-l,3,2-oxathiaphospholane] (2), if successfully separated into diastereoisomeric species, may undergo nucleophilic attack by the 5'-hydroxyl function of a 3'-blocked nucleoside (3) in a stereospecific manner. Subsequent ellimination of ethylene sulfide should provide dinucleoside (3', 5')phosphorothioate {4).
To check this hypothesis, we prepared compounds 2, by reaction of appropriately protected nucleosides with 2-A^-diisopropylamino-l,3,2-oxathiaphospholane (5) (11) HPTLC, HPLC and 3I P NMR. Physicochemical characteristics of the diastereoisomers of 2 are presented in Table 1 .
In the case of 5'-DMT-thymidine 3'-O[2-thio-l,3,2-oxathiaphospholane] the 'fast' eluted isomer 2 (B=Thy) was treated with p-toluenesulfonic acid for deprotection of the 5'-hydroxyl function. The resulting thymidine 3'-O[2-thio-l,3,2-oxathiaphospholane], upon treatment with triethylamine, underwent intramolecular cyclization to afford thymidine cyclic (3', 5')-Spphosphorothioate, ([Sp]-cTMPS) (12) . In the same manner, the 'slow' eluted diastereomer of 2 (B=Thy) gave [Rp]-cTMPS (12) . The results of these interconversions proved that intramolecular opening of the oxathiaphospholane ring is stereospecific and kindled hopes that intermolecular ring opening in 2 followed by elimination of ethylene sulfide could also be stereospecific.
Reaction of 'fast' eluted 2 (B=Thy) with thymidine 3 (bound to solid support via the 3'oxygen) in acetonitrile in the presence of triethylamine appeared to proceed slowly. After 0.5 h, the product obtained via deprotection and cleavage from the support was isolated in only 5% yield (HPLC assay), but appeared to be [Sp]-dithymidylyl (3', 5') phosphorothioate (T PS T, 4, B=B'=Thy, R'=OH), by comparison with authentic material (13) . In the search for other catalysts, including Nmethylimidazole, 4-dimethylaminopyridine (DMAP), and some others, l,8-diazabicyclo [5.4 .0] undec-7-ene (DBU) appeared to be the catayst of choice. The same reaction as above when performed in the presence of a 300-fold molar excess of DBU gave (HPLC assay) the crude [Sp]T PS T (4) in 95% yield. Diastereoisomeric purity (d.p.) of the resultant product was Table 2 . This first set of experiments had proved that: (1) reaction of 2 with the 5'-hydroxyl function of an appropriately protected nucleoside in the presence of DBU effectively leads to formation of dinucleoside phosphorothioates, and (2) this process is fully stereospecific. Automated synthesis of oligo(deoxyribonucleoside phosphorothioates) (7) based on the aforementioned results required the solution of a few problems. The first one was posed by the lability of the conventional LCA-CPG linker to DBU (14) . Fortunately, it was demonstrated by Gait (15) that a sarcosinederived linker originally proposed by Brown (16) is resistant against DBU. The set of T, C Bz , G Bu , A Bz -bound to CPG via a sarcosinyl linker was therefore prepared and used for further solid-support syntheses. The next two tasks were posed by the fact that, in the process of ring opening of 2 followed by ethylene sulfide elimination, an unprotected internucleotide phosphorothioate function is formed, and this moiety could potentially complicate the next cycle of oligomer elongation by either branch formulation, via an unsymmetrical pyrophosphorodithioate, or acylations during the capping step. This latter event had been exemplified in earlier observations that trifluoroacetic anhydride effectively oxidizes neutral phosphorothioates (17, 18) . We have proved experimentally that phosphorothioylation of dialkyl phosphorothioate by means of 2/DBU does not occur. It was also demonstrated that treatment of dithymidylyl (3',5')-phosphorothioate with acetic anhydride/DMAP for 60 minutes does not lead to conversion of phosphorothioate-to-phosphate. With these results, an initial protocol for automated synthesis of oligo(deoxyribonucleoside phosphorothioates) has been elaborated (Table 3 ).
According to this protocol, the following oligonucleotides were (9) (19) .
Each synthesis was first performed using unseparated diastereoisomers of 2 which led to a random mixture of diastereoisomers of target oligonucleotides, and these were Table 4 . HPLC characteristics of oligo(deoxyribonucleoside phosphorothioates)
Comp. No. compared with reference samples of the corresponding oligonucleotides prepared by the conventional phosphoramidite approach using stepwise sulfurization during each reaction cycle (5) (data not presented). HPLC examination has shown the identity of oligo(nucleoside phosphorothioates) obtained according to these two different methodologies.
NMR investigation ( 3I P NMR) has shown that the content of phosphates is < ca. 1%.
Independently, oligomers 6, 7and 8 have been prepared using separated diastereoisomers of 2.
The correctness of the structure of each stereoregular oligonucleotide phosphorothioate was checked by enzymatic and electrophoretic methods (Figure 4) .
The use of two nucleolytic enzymes (svPDE -EC.3.1.4.1 and nuclease PI -EC.3.1.30.1) with known diastereoselectivity towards dinucleoside phosphorothioates allowed us to confirm the diastereoisomeric purity of stereoregular oligo(nucleoside phosphorothioates). While svPDE recognizes and hydrolyzes only Rp-isomers of dinucleoside phosphorothioates (20, 21) , nuclease PI is known to hydrolyze their Sp-isomers (22) . Compounds designated as [Rp]-<5and [Sp]-<5 were incubated with svPDE and, independently, with nuclease PI. HPLC analysis performed under conditions described in Table 4 revealed complete resistance of [Rp]-6to nuclease PI and its complete degradation in the presence of svPDE. In agreement with these results, the Sp-isomer of 6 appeared to be resistant to svPDE, but hydrolyzed in the presence of nuclease PI. These results proved high (above 97%) diastereoisomeric purity of [Rp]-6 and [Sp]-6.
The same method of analysis was applied to Rp-and Spisomers of d[(C PS )4C] which were synthesized using mutually cross-contaminated (5%) diastereoisomers of 2 (B=C Bz ). In the case of these pentanucleotides, enzymatic degradation and HPLC ]-S only one of two enzymes was used (svPDE or nPl), enzymatic analyses of the random mixture of diastereomers of 9 required simultaneous use of svPDE and PI followed by the use of alkaline phosphatase. In this case, the mixture of nucleosides A, G, C, T was obtained as the final product.
In conclusion, we would like to emphasize that we have established a new and effective method for synthesis of oligo(nucleoside phosphorothioates), which is based on novel chemistry, and is both simple and cost-effective. We have proven that this method, when utilizing separated diastereoisomers of 2, is stereospecific and leads to stereoregular oligonucleotides with predetermined chirality at each phosphorothioate center. Due to the known antiviral activity of anti-rev (9), which so far has been prepared and studied as the random mixture of diastereoisomers, the synthesis of stereoregular [all-Rp]-9 and [all-Sp]-9 is in progress with the purpose of evaluation of the problem of structure-activity relationship. One has to realize, however, that the synthesis of 28-mer with a step yield of 95 % and stereospecificity of single coupling 99%, leads to product prepared in 25 % yield, which theoretically may contain only 76% of the single diastereomer having predetermined chirality at each phosphorus atom.
